Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1594 participants
OBSERVATIONAL
2013-04-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of New Cardiac Biomarkers in Elderly Patients Undergoing Cardiac Surgery
NCT00416299
Effects of Personality and Context on Recovery From Coronary Artery Bypass
NCT00005334
A Prediction Model for 1-year Mortality After Valvular Heart Surgery
NCT05833256
Prediction of Chronic Pain in Cardiac Surgery: Evaluation by Algocartography Predict-ALGOCARTE
NCT06681272
Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery
NCT02068716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac surgical operation (valve, aorta, coronary arteries)
Quality of life assessment using EQ-5D-3L
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willingness to participate,
* ability to comprehend Finnish language
Exclusion Criteria
* not willing to participate,
* blind or other disturbance in seeing,
* inability to comprehend Finnish language
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University
OTHER
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jari Laurikka, MD,PhD
Role: STUDY_DIRECTOR
Head of Department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R12265
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.